issued
on 19 Nov 2024
Last Applicant/ Owned by
CH-4002
Basel
CH
4002
Serial Number
98411925 filed on 20th Feb 2024
Registration Number
N/A
Correspondent Address
Maury M. Tepper, III
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, and neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degenerat Read More
Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, and neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
N/A
N/A
No 98411925
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
19th Nov 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
08th Oct 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
08th Oct 2024 | PUBLISHED FOR OPPOSITION |
18th Sep 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
04th Sep 2024 | EXAMINERS AMENDMENT E-MAILED |
04th Sep 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
04th Sep 2024 | EXAMINER'S AMENDMENT ENTERED |
04th Sep 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
04th Sep 2024 | EXAMINERS AMENDMENT -WRITTEN |
03rd Sep 2024 | NON-FINAL ACTION E-MAILED |